ENGN (enGene Holdings Inc) Sotuvning yalpi marjinal rentabelligi

enGene Corp (ENGN) kompaniyasining rasmiy ramzlari

enGene Holdings Inc. (ENGN) tomonidan shilliq qavatlar uchun gen yetkazib berish tizimlarining ishlab chiqilishi yuqori binary xatarlarni yuzaga keltirmoqda, bu esa GURU.Markets kotirovkalarida aks etgan yalpi foyda koeffitsiyentiga ta'sir qiladi; 0.00 qiymati esa eng so'nggi raqamni ko'rsatadi. Logistikada haroratning samarali nazorati daromadlilikni qo'llab-quvvatlaydi, biroq sanksiya to'siqlari va mamlakatlarning siyosiy izolyatsiyasi yangi dori vositalarining global sertifikatsiyasiga sezilarli darajada to'sqinlik qilmoqda.

Yalpi rentabellik: enGene Holdings Inc (ENGN) 21.02.2024 - 20.11.2026 uchun

enGene Holdings Inc. (ENGN) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- kotirovkalar va tahlilchilar prognozi:
- biznesning bozor baholash ko'rsatkichlari:
- pul qoldiqlari va pul oqimlari ma'lumotlari:
Fundamental baholash:enGene Holdings Inc (ENGN)
enGene Corp brend mahsuloti

Yalpi marja mahsulotni yaratish xarajatlaridan keyin qolgan daromad qismini aniqlash orqali bevosita ishlab chiqarish samaradorligini o'lchaydi. Saraton terapiyasi ekotizimi tartibga soluvchi organlarning tasdig'ini va klinik sinovlarning yakunlanishini kutayotgan enGene Holdings Inc. (ENGN) uchun yalpi rentabellik tijoratlashtirishga operatsion tayyorgarlik ko'rsatkichi bo'lib xizmat qiladi va investorlarga kelajakdagi mahsulotning har bir birligining foyda potentsialini baholash imkonini beradi.

Asosiy raqobatchilar

argenx - Yalpi foyda normasi|Yalpi rentabellik biontech.de|ABIVAX (ABVX) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja ADMA|Yalpi foyda koeffitsiyenti PTGX|Yalpi rentabellik Immunovant Corp IMVT|Yalpi marja Kiniksa Pharmaceuticals, Ltd. KNSA|GRFS - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Adaptive Biotechnologies ADPT|CLDX (Celldex Therapeutics, Inc.) - Yalpi foyda bo'yicha rentabellik|Aurinia Pharmaceuticals Inc. (AUPH) - Yalpi marja|Yalpi foyda bo'yicha rentabellik BCRX|Yalpi foyda marjasi Vera Therapeutics Inc VERA|Yalpi foyda bo'yicha rentabellik DNTH (Dianthus Pharma)|Yalpi foyda bo'yicha sotuv rentabelligi Pharvaris N.V.|AbCellera Biologics Inc - Yalpi foyda bo'yicha rentabellik|Tourmaline Bio (TRML) - Yalpi foyda marjasi|PGEN - Yalpi rentabellik|Yalpi foyda normasi PHAR (Pharming Group NV)|NKTR: Yalpi marja|Upstream Bio Corp - Yalpi foyda normasi|Yalpi rentabellik Zenas Biopharma Inc|Immunome, Inc. (IMNM) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOSS|Yalpi foyda bo'yicha rentabellik KalVista Pharmaceuticals, Inc. KALV|Yalpi rentabellik Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Yalpi foyda marjasi|SVRA - Yalpi rentabellik|Rigel Pharmaceuticals - Yalpi foyda koeffitsiyenti|AnaptysBio Corp (ANAB) - Yalpi rentabellik|ATXS - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi foyda bo'yicha rentabellik RAPT|JBIO (Aerovate Therapeutics Inc) - Yalpi foyda koeffitsiyenti|Yalpi marja ACRS|Yalpi foyda bo'yicha rentabellik kyvernatx.com KYTX|Yalpi marja TLSA (Tiziana Life Sciences, Ltd.)|Yalpi marja Cabaletta Bio CABA|VTYX: Yalpi foyda bo'yicha rentabellik|Theratechnologies Inc. (THTX) - Yalpi foyda bo'yicha rentabellik|AVTX: Yalpi marja|ELDN - Yalpi foyda bo'yicha sotuv rentabelligi|AGEN (Agenus, Inc) - Yalpi marja|Yalpi marja Climb Bio, Inc.|Yalpi rentabellik Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Yalpi foyda normasi|Yalpi marja ADAG (Adagene Inc)|IMA - Yalpi foyda bo'yicha rentabellik|STTK - Yalpi rentabellik|EQ (equilliumbio.com) - Sotuvning yalpi rentabelligi|CNTB: Yalpi marja|Immunic Inc (IMUX) - Yalpi marja|ATRA (Atara Biotherapeutics Inc) - Yalpi marja|Sotuvning yalpi rentabelligi IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Yalpi foyda normasi|Adicet Bio, Inc. - Sotuvning yalpi rentabelligi|Celularity Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja INmune Bio Corporation INMB|Barinthus Biotherapeutics - Yalpi marja|Kezar Life Sciences, Inc. (KZR) - Yalpi foyda bo'yicha rentabellik|SAB Biotherapeutics Inc. (SABS) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Akari Therapeutics plc|Yalpi rentabellik enlivex.com|q32bio.com (QTTB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja GOVX|Edesa Biotech, Inc. - Sotuvning yalpi rentabelligi|iBio Inc - Yalpi foyda bo'yicha rentabellik|Yalpi marja Carisma Therapeutics CARM|XTLB - Yalpi rentabellik|BOLT (boltbio.com) - Sotuvning yalpi rentabelligi|HCWB: Yalpi marja|Aptevo (APVO) - Yalpi marja|Yalpi rentabellik AIM ImmunoTech|Yalpi foyda bo'yicha rentabellik Aditxt (ADTX)|Yalpi foyda bo'yicha rentabellik GRI (GRI Bio Corporation)|XORTX - Sotuvning yalpi rentabelligi|Yalpi marja HIND (Vyome Holdings Inc.)|Yalpi foyda normasi REVB|Indaptus - Yalpi marja|SCNI (Scinai Immunotherapeutics Ltd.) - Sotuvning yalpi rentabelligi|CALI: Yalpi marja|Affimed NV - Yalpi foyda normasi|Yalpi rentabellik Allakos Inc.|Yalpi marja HOOKIPA Pharma|Yalpi rentabellik IGM Biosciences, Inc. (IGMS)|ITOS - Yalpi foyda marjasi|Yalpi marja OCEA (Ocean Bio)|Yalpi foyda normasi TCBP|THRD - Yalpi rentabellik